特别提示：包括重组小鼠TNFRSF1B在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组小鼠TNFRSF1B
英文名称：Recombinant Mouse Tumor Necrosis Factor Receptor II
产品货号：JN0472
产品规格：10μg|50μg|500μg|1mg

本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Val23-Gly258在C端含有His标签。

TNFRSF1B质量控制：＞95%(还原性SDS-PAGE)

TNFRSF1B制剂：冻干品

TNFRSF1B保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

TNFRSF1B复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于TNFRSF1B：
Tumor Necrosis Factor Receptor Superfamily Member 1B (TNFRSF1B) is a member of the Tumor Necrosis Factor Receptor Superfamily. TNFRSF1B contains four TNFR-Cys repeats. TNFRSF1B can be cleaved into the following 2 chains: Tumor necrosis factor receptor superfamily member 1b and membrane form and Tumor necrosis factor-binding protein 2. TNFRSF1B is a receptor with high affinity for TNFSF2/TNF-α and approximately 5-fold lower affinity for homotrimeric TNFSF1/lymphotoxin-α. TNFRSF1B mediates most of the metabolic effects of TNF-α. TNF-α-induced apoptosis suggests that it regulates TNF-α function by antagonizing its biological activity.

根据您的关注的重组小鼠TNFRSF1B，重组Tumor Necrosis Factor Receptor II，重组小鼠Tumor Necrosis Factor Receptor II，Recombinant Mouse Tumor Necrosis Factor Receptor II，您可能还对以下产品有需求：



名称：重组小鼠DR6(TNFRSF21)
货号：JN0465
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Gln42-His349在C端含有Fc标签和His标签

DR6/TNFRSF21质量控制：＞95%(还原性SDS-PAGE)

DR6/TNFRSF21制剂：冻干品

DR6/TNFRSF21保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

DR6/TNFRSF21复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于DR6/TNFRSF21：
Tumor necrosis factor receptor superfamily member 21(DR6) is a single-pass type I membrane protein and contains 1 death domain and 4 TNFR-Cys repeats. The protein may activate NF-kappa-B and promote apoptosis and it may activate JNK and be involved in T-cell differentiation.It is required for both normal cell body death and axonal pruning. Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to release sAPP-beta which is further cleaved to release an N-terminal fragment of APP (N-APP). N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6).

关注重组小鼠TNFRSF1B，重组Tumor Necrosis Factor Receptor II，重组小鼠Tumor Necrosis Factor Receptor II，Recombinant Mouse Tumor Necrosis Factor Receptor II的同时，为您推荐更多您可能感兴趣的产品：
 

货号	名称	规格
JN1987	重组人C-反应蛋白(CRP)	10μg|50μg|500μg|1mg
JN2019	重组人磷酸甘露糖变位酶1(PMM1)	10μg|50μg|500μg|1mg
JN0879	重组人转录抑制蛋白1(DR1)	10μg|50μg|500μg|1mg
JN0912	重组人过氧化物还原蛋白4(过氧还蛋白4)(Prx4)	10μg|50μg|500μg|1mg
JN1100	重组人连接黏附分子B(JAM-B)	10μg|50μg|500μg|1mg
JN1144	重组人PIK3IP1(磷脂酰肌醇-3激酶相互作用蛋白1)	10μg|50μg|500μg|1mg